Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Helman

Showing results (11-20 of 211) with videos related to

Pageof 22
Sort By:
Annual Review of Medicine|January 18, 2006
Molecular approaches in pediatric oncologyChand Khanna, Lee J Helman
Nature Medicine|May 19, 1998
Glimpsing the cause of rhabdomyosarcomaS Zhan, L J Helman
JAMA Oncology|January 30, 2016
Precision Therapy for Pediatric CancersJaved Khan, Lee J Helman
JAMA|October 3, 1977
Metastatic bone diseaseN Helman, A J Helman
Neoplasia (New York, N.Y.)|August 23, 2002
Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathwayXiaolin Wan, Lee J Helman
Nature Reviews. Cancer|September 3, 2003
Mechanisms of sarcoma developmentLee J Helman, Paul Meltzer
Oncogene|November 7, 2003
Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cellsXiaolin Wan, Lee J Helman
Oncogene|September 28, 1999
Rhabdomyosarcoma--working out the pathwaysG Merlino, L J Helman
The Oncologist|September 4, 2007
The biology behind mTOR inhibition in sarcomaXiaolin Wan, Lee J Helman
Pharmacology & Therapeutics|October 23, 2012
Prospects and challenges for the development of new therapies for Ewing sarcomaPatrick J Grohar, Lee J Helman
Pageof 22

Showing results (11-20 of 211) with videos related to

Sort By:
Pageof 22
Annual Review of Medicine|January 18, 2006
Molecular approaches in pediatric oncologyChand Khanna, Lee J Helman
Nature Medicine|May 19, 1998
Glimpsing the cause of rhabdomyosarcomaS Zhan, L J Helman
JAMA Oncology|January 30, 2016
Precision Therapy for Pediatric CancersJaved Khan, Lee J Helman
JAMA|October 3, 1977
Metastatic bone diseaseN Helman, A J Helman
Neoplasia (New York, N.Y.)|August 23, 2002
Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathwayXiaolin Wan, Lee J Helman
Nature Reviews. Cancer|September 3, 2003
Mechanisms of sarcoma developmentLee J Helman, Paul Meltzer
Oncogene|November 7, 2003
Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cellsXiaolin Wan, Lee J Helman
Oncogene|September 28, 1999
Rhabdomyosarcoma--working out the pathwaysG Merlino, L J Helman
The Oncologist|September 4, 2007
The biology behind mTOR inhibition in sarcomaXiaolin Wan, Lee J Helman
Pharmacology & Therapeutics|October 23, 2012
Prospects and challenges for the development of new therapies for Ewing sarcomaPatrick J Grohar, Lee J Helman
Pageof 22